Paper39248263
Mineralocorticoid Receptor Blocker Prevents Mineralocorticoid Receptor-Mediated Inflammation by Modulating Transcriptional Activity of Mineralocorticoid Receptor-p65-Signal Transducer and Activator of Transcription 3 Complex.
Kuyama N and 12 others. J Am Heart Assoc, 2024. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Mineralocorticoid Receptor Blocker Prevents Mineralocorticoid Receptor-Mediated Inflammation by Modulating Transcriptional Activity of Mineralocorticoid Receptor-p65-Signal Transducer and Activator of Transcription 3 Complex. Papers, record 39248263. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39248263
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Mineralocorticoid Receptor Blocker Prevents Mineralocorticoid Receptor-Mediated Inflammation by Modulating Transcriptional Activity of Mineralocorticoid Receptor-p65-Signal Transducer and Activator of Transcription 3 Complex.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| STAT3 Transcription Factor | Major topic |
| Receptors, Mineralocorticoid | Major topic |
| Mice, Inbred C57BL | Major topic |
| Mineralocorticoid Receptor Antagonists | Major topic |
| Disease Models, Animal | Major topic |
| Myocardial Infarction | Major topic |
| Transcription Factor RelA | Major topic |
| Sulfones | Major topic |
| Animals | |
| Male | |
| Mice | |
| RAW 264.7 Cells | |
| Signal Transduction | |
| Fibrosis | |
| Transcription, Genetic | |
| Myocardium | |
| Anti-Inflammatory Agents | |
| Interleukin-6 | |
| Pyrroles |
Source PubMed
References53
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28855315 | Eplerenone prevented obesity-induced inflammasome activation and glucose intolerance. | J Endocrinol | 2017 | https://conductscience.org/library/papers/28855315 | PubMed |
| 2 | 26073023 | Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist. | Eur J Pharmacol | 2015 | https://conductscience.org/library/papers/26073023 | PubMed |
| 3 | 19299019 | STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria. | Mol Immunol | 2009 | https://conductscience.org/library/papers/19299019 | PubMed |
| 4 | 31635187 | MicroRNA Mediate Visfatin and Resistin Induction of Oxidative Stress in Human Osteoarthritic Synovial Fibroblasts Via NF-κB Pathway. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31635187 | PubMed |
| 5 | 8290595 | Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. | Proc Natl Acad Sci U S A | 1994 | https://conductscience.org/library/papers/8290595 | PubMed |
| 6 | 23774812 | Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis. | Nat Rev Nephrol | 2013 | https://conductscience.org/library/papers/23774812 | PubMed |
| 7 | 28943877 | β-Catenin Directs Nuclear Factor-κB p65 Output via CREB-Binding Protein/p300 in Human Airway Smooth Muscle. | Front Immunol | 2017 | https://conductscience.org/library/papers/28943877 | PubMed |
| 8 | 22705886 | Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-κB. | Circulation | 2012 | https://conductscience.org/library/papers/22705886 | PubMed |
| 9 | 23629805 | Novel mechanism for disrupted circadian blood pressure rhythm in a rat model of metabolic syndrome--the critical role of angiotensin II. | J Am Heart Assoc | 2013 | https://conductscience.org/library/papers/23629805 | PubMed |
| 10 | 23178493 | Essential role of cooperative NF-κB and Stat3 recruitment to ICAM-1 intronic consensus elements in the regulation of radiation-induced invasion and migration in glioma. | Oncogene | 2013 | https://conductscience.org/library/papers/23178493 | PubMed |
| 11 | 12974768 | Spironolactone inhibits production of proinflammatory cytokines, including tumour necrosis factor-alpha and interferon-gamma, and has potential in the treatment of arthritis. | Clin Exp Immunol | 2003 | https://conductscience.org/library/papers/12974768 | PubMed |
| 12 | 20697155 | Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice. | J Clin Invest | 2010 | https://conductscience.org/library/papers/20697155 | PubMed |
| 13 | 9250404 | Major stress protein Hsp70 interacts with NF-kB regulatory complex in human T-lymphoma cells. | Cell Stress Chaperones | 1997 | https://conductscience.org/library/papers/9250404 | PubMed |
| 14 | 16166378 | A c-Rel subdomain responsible for enhanced DNA-binding affinity and selective gene activation. | Genes Dev | 2005 | https://conductscience.org/library/papers/16166378 | PubMed |
| 15 | 26872673 | The role of inflammation and cell death in the pathogenesis, progression and treatment of heart failure. | Heart Fail Rev | 2016 | https://conductscience.org/library/papers/26872673 | PubMed |
| 16 | 31991486 | Crystal structure of the mineralocorticoid receptor ligand-binding domain in complex with a potent and selective nonsteroidal blocker, esaxerenone (CS-3150). | FEBS Lett | 2020 | https://conductscience.org/library/papers/31991486 | PubMed |
| 17 | 33669786 | Cardioprotective Effects of a Nonsteroidal Mineralocorticoid Receptor Blocker, Esaxerenone, in Dahl Salt-Sensitive Hypertensive Rats. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33669786 | PubMed |
| 18 | 22659623 | The mineralocorticoid receptor-p38MAPK-NFκB or ERK-Sp1 signal pathways mediate aldosterone-stimulated inflammatory and profibrotic responses in rat vascular smooth muscle cells. | Acta Pharmacol Sin | 2012 | https://conductscience.org/library/papers/22659623 | PubMed |
| 19 | 15173056 | Inflammation as a cardiovascular risk factor. | Circulation | 2004 | https://conductscience.org/library/papers/15173056 | PubMed |
| 20 | 20660817 | Intracardiac injection of AdGRK5-NT reduces left ventricular hypertrophy by inhibiting NF-kappaB-dependent hypertrophic gene expression. | Hypertension | 2010 | https://conductscience.org/library/papers/20660817 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42469710 | Non-steroidal mineralocorticoid receptor antagonists in non-diabetic kidney disease: a narrative review of mechanisms and clinical advances. | BMC Nephrol | 2026 | https://conductscience.org/library/papers/42469710 | PubMed |
| 42414546 | Age-associated niche remodeling drives dental pulp progenitor dysfunction and fibrosis. | Commun Biol | 2026 | https://conductscience.org/library/papers/42414546 | PubMed |
| 42358614 | Myeloid cell renin-angiotensin-aldosterone system in hypertension and inflammation. | Curr Opin Physiol | 2026 | https://conductscience.org/library/papers/42358614 | PubMed |
| 41095684 | Exploring the Plasma Fatty Acid Signature of Primary Aldosteronism: Comparison with Essential Hypertension and Longitudinal Therapy Effects. | Diagnostics (Basel) | 2025 | https://conductscience.org/library/papers/41095684 | PubMed |
| 40157997 | Blocking mineralocorticoid signaling with esaxerenone reduces atherosclerosis in hyperglycemic ApoE KO mice without affecting blood pressure and glycolipid metabolism. | Sci Rep | 2025 | https://conductscience.org/library/papers/40157997 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39248263
GET https://conductscience.org/api/papers/v1/39248263/references?page=2